DETECTION OF TRANSFORMING GROWTH-FACTOR BETA1 MESSENGER-RNA IN CEREBROSPINAL-FLUID CELLS OF PATIENTS WITH MENINGITIS BY NONRADIOACTIVE IN-SITU HYBRIDIZATION

被引:21
作者
OSSEGE, LM [1 ]
VOSS, B [1 ]
WIETHEGE, T [1 ]
SINDERN, E [1 ]
MALIN, JP [1 ]
机构
[1] PROFESS ASSOC,OCCUPAT HLTH RES INST,BOCHUM,GERMANY
关键词
MENINGITIS; TRANSFORMING GROWTH FACTOR BETA; TRANSCELLULAR SIGNALING; NONRADIOACTIVE IN SITU HYBRIDIZATION; CEREBROSPINAL FLUID CELLS;
D O I
10.1007/BF00920569
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Meningitis is a serious disease mostly caused by viral or bacterial infections. In complicated cases it may lead to brain damage and death. The infection and cell damage result in a cellular and immunological response. Following this, a high secretion of cytokines can be expected. Cytokines, especially tumour necrosis factor alpha (TNF-alpha) and interleukin-1 (IL-1), promote the inflammatory reactions in the subarachnoid space. Transforming growth factor beta1 (TGF-beta1) has antagonistic effects on TNF-alpha and IL-1-mediated processes. Therefore, it suppresses inflammatory reactions. To observe the expression of TGF-beta1 in transcellular signalling in the inflammatory processes of meningitis, we investigated TGF-beta1 mRNA in cells in the cerebrospinal fluid of three patients with meningitis by non-radioactive in situ hybridization. All patients fulfilled the usual clinical criteria of meningitis. In one case Neisseria menigitidis could be identified as the pathogenic agent. In the remainder, no agent could be isolated. In all cytological preparations of the cerebrospinal fluid of these patients a high level of TGF-beta1 mRNA was detectable in the cell populations. It was possible to distinguish between the different cell types of the cerebrospinal fluid and to attach the mRNA expression to them. On the one hand, this makes it possible to investigate pathogenesis and defence mechanisms in bacterial and aseptic meningitis on a cellular level; on the other hand, it may open new perspectives in the control of disease development, prognosis, diagnosis and supporting therapy.
引用
收藏
页码:14 / 19
页数:6
相关论文
共 21 条
[2]   INHIBITION OF CYTOKINE PRODUCTION BY CYCLOSPORINE-A AND TRANSFORMING GROWTH-FACTOR-BETA [J].
ESPEVIK, T ;
FIGARI, IS ;
SHALABY, MR ;
LACKIDES, GA ;
LEWIS, GD ;
SHEPARD, HM ;
PALLADINO, MA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1987, 166 (02) :571-576
[3]   A TECHNIQUE FOR RADIOLABELING DNA RESTRICTION ENDONUCLEASE FRAGMENTS TO HIGH SPECIFIC ACTIVITY [J].
FEINBERG, AP ;
VOGELSTEIN, B .
ANALYTICAL BIOCHEMISTRY, 1983, 132 (01) :6-13
[4]   MODULATION OF THE IMMUNE-RESPONSE BY TRANSFORMING GROWTH-FACTOR-BETA [J].
FONTANA, A ;
CONSTAM, DB ;
FREI, K ;
MALIPIERO, U ;
PFISTER, HW .
INTERNATIONAL ARCHIVES OF ALLERGY AND IMMUNOLOGY, 1992, 99 (01) :1-7
[5]  
FREI K, 1993, INT REV EXP PATHOL, V34, P183
[6]   PRODUCTION OF TRANSFORMING GROWTH-FACTOR BETA BY HUMAN PERIPHERAL-BLOOD MONOCYTES AND NEUTROPHILS [J].
GROTENDORST, GR ;
SMALE, G ;
PENCEV, D .
JOURNAL OF CELLULAR PHYSIOLOGY, 1989, 140 (02) :396-402
[7]  
IBELGAUFTS H, 1992, LEXIKON ZYTOKINE, P220
[8]   PRODUCTION OF TRANSFORMING GROWTH-FACTOR-BETA BY HUMAN LYMPHOCYTES-T AND ITS POTENTIAL ROLE IN THE REGULATION OF T-CELL GROWTH [J].
KEHRL, JH ;
WAKEFIELD, LM ;
ROBERTS, AB ;
JAKOWLEW, S ;
ALVAREZMON, M ;
DERYNCK, R ;
SPORN, MB ;
FAUCI, AS .
JOURNAL OF EXPERIMENTAL MEDICINE, 1986, 163 (05) :1037-1050
[9]  
KEHRL JH, 1986, J IMMUNOL, V137, P3855
[10]   TRANSFORMING GROWTH-FACTOR-BETA - MECHANISM OF ACTION AND CLINICAL-SIGNIFICANCE [J].
KEKOW, J ;
GROSS, WL .
DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1992, 117 (06) :228-235